REVIVA PHARMA HLDGS INC
RVPH
RVPH was delisted on the 13th of May, 2026.
13 hedge funds and large institutions have $7.54M invested in REVIVA PHARMA HLDGS INC in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
8% more funds holding
Funds holding: 12 → 13 (+1)
0.04% less ownership
Funds ownership: 0.97% → 0.93% (-0.04%)
28% less capital invested
Capital invested by funds: $10.5M → $7.54M (-$3.01M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$274K |
| 2 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
+$33.1K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$13.6K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$6.2K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.35K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$88.4K |
| 2 |
ECM
EMC Capital Management
Houston,
Texas
|
-$74K |
| 3 |
HF
HRT Financial
New York
|
-$54K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$52.2K |
| 5 |
BlackRock
New York
|
-$30.8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TCM
1
Tang Capital Management
San Diego,
California
| $3.47M | – | – | – |
|
|
AC
2
Armistice Capital
New York
| $2.04M | +$274K | +3,844 | +12% |
|
|
3
Vanguard Group
Malvern,
Pennsylvania
| $1.43M | -$52.2K | -733 | -3% |
|
4
Geode Capital Management
Boston,
Massachusetts
| $217K | – | – | – |
|
|
ECM
5
EMC Capital Management
Houston,
Texas
| $159K | -$74K | -1,038 | -27% |
|
|
6
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $80K | +$6.2K | +87 | +7% |
|
|
7
BlackRock
New York
| $71K | -$30.8K | -432 | -26% |
|
8
Northern Trust
Chicago,
Illinois
| $31K | – | – | – |
|
|
9
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| $27K | +$33.1K | +465 | New |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| $11K | +$13.6K | +191 | New |
|
|
11
UBS Group
Zurich,
Switzerland
| $6K | +$1.35K | +19 | +24% |
|
|
12
Bank of America
Charlotte,
North Carolina
| – | -$88.4K | -1,240 | Closed |
|
|
HF
13
HRT Financial
New York
| – | -$54K | -673 | Closed |
|
14
Wells Fargo
San Francisco,
California
| – | +$214 | +3 | +150% |
|
|
WAM
15
Wolverine Asset Management
Chicago,
Illinois
| – | +$641 | +9 | New |
|
RVPH Hedge Fund Activity: Q4 2021 in Review
13 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in REVIVA PHARMA HLDGS INC (RVPH) for Q4 2021, worth a combined $7.54M — down 28% from $10.5M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new RVPH positions and 2 closed out — a net gain of 1 holder — while 4 added to existing stakes and 3 trimmed.
The largest buyer was Armistice Capital, adding an estimated $274K. The largest seller was Bank of America, exiting entirely with an estimated $88.4K sold.
- 13 institutional investors held REVIVA PHARMA HLDGS INC (RVPH) as of Q4 2021, up from 12 in Q3 2021.
- Funds reported $7.54M of REVIVA PHARMA HLDGS INC stock for Q4 2021, down 28% quarter-over-quarter.
- 3 funds opened new REVIVA PHARMA HLDGS INC positions in Q4 2021 and 2 closed out, a net change of +1 holder.
- The largest REVIVA PHARMA HLDGS INC buyer in Q4 2021 was Armistice Capital, an estimated $274K added.
- The largest REVIVA PHARMA HLDGS INC seller in Q4 2021 was Bank of America, an estimated $88.4K sold.
Based on aggregated 13F filings for Q4 2021.